Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | X8ZC7V0OX3 |
InChI Key | DZGWFCGJZKJUFP-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C8H11NO |
Molecular Weight | 137.18 |
AlogP | 0.89 |
Hydrogen Bond Acceptor | 2.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 2.0 |
Polar Surface Area | 46.25 |
Molecular species | BASE |
Aromatic Rings | 1.0 |
Heavy Atoms | 10.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Oxidoreductase
|
- | - | - | - | 23 | |
Ion channel
Ligand-gated ion channel
5HT3 receptor
|
26000 | - | 8511-8511 | - | - | |
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Serotonin receptor
|
- | - | 8511-8511 | - | - | |
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Trace amine receptor
|
69 | - | - | - | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 60 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Parkinson Disease | 3 | D010300 | ClinicalTrials |
Hypotension, Orthostatic | 1 | D007024 | ClinicalTrials |
Orthostatic Intolerance | 1 | D054971 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 51-67-2 |
ChEBI | 15760 |
ChEMBL | CHEMBL11608 |
DrugBank | DB08841 |
DrugCentral | 2784 |
EPA CompTox | DTXSID2043874 |
FDA SRS | X8ZC7V0OX3 |
Human Metabolome Database | HMDB0000306 |
Guide to Pharmacology | 2150 |
KEGG | C00483 |
PDB | AEF |
PubChem | 5610 |
SureChEMBL | SCHEMBL4111 |
ZINC | ZINC000000002233 |